openPR Logo
Press release

Trends in the Ready To Use Blood Cancer Diagnostics Market 2018-2020

02-13-2019 09:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Blood Cancer Diagnostics

Blood Cancer Diagnostics

Increase in the prevalence of oncological diseases and technological advancements in diagnostics are positively impacting the global blood cancer diagnostics market. Focus on detecting cancer at an early stage through molecular and RNA/DNA testing can widely improve the diagnosis. As spending on healthcare witnesses a gradual increase in developing countries, the overall blood cancer diagnostics market is projected to grow at a steady rate during the forecast period 2017-2022. According to Fact.MR’s analysis, the global blood cancer diagnostics market is projected to grow at a steady CAGR during the forecast period.

Fact.MR’s report offers market analysis and forecast on the global blood cancer diagnostics market on the basis of test type. Liquid biopsy is another test type that remains widely used among end-users. Studies have shown that liquid biopsy can overcome challenges related to intra- and inter-tumor heterogeneity. The research was carried out at Harvard Medical School and Massachusetts General Hospital Cancer Center. Inclusion of liquid biopsy can help in identifying resistance alternations in patients with advanced cholangiocarcinoma. On account of growing preference for liquid biopsy, this segment is projected to increase at a CAGR of over 10% through 2022.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=47

According to the report, the CBC test segment type of the global blood cancer market is valued at nearly US$ 77 million in 2017. By 2022, this is projected to grow at a healthy rate. The market in North America will remain lucrative for manufacturers throughout the forecast period. The CTC tests segment on the other hand, is anticipated to grow at a relatively higher CAGR than the CBC test segments.

Owing to accuracy and convenience of blood testing protein test type, it is anticipated that more end-use sectors will continue to use this type of testing globally. Fact.MR estimates the global blood protein testing market to rake in significant revenues during the forecast period.

By end-users, hospital associated labs account for a significant percentage of the global blood cancer diagnostics market. Valued at over US$ 136 million in 2017, the hospital associated labs segment is projected to surpass US$ 180 million in revenues by 2022. Demand from hospital associated labs segment is projected to grow at a steady CAGR during the forecast period.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=47

Competition Tracking

The key companies profiled in Fact.MR’s research include Abbott Laboratories, Roche Holding A.G., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Myriad Genetics Inc., NanoString Technologies Inc, NeoGenomics Laboratories, Inc., Siemens AG, Quest Diagnostics Incorporated, Qiagen N.V., Agilent Technologies, Biotheranostics, Inc, Almac Group Limited, and GeneNews Limited.

Overall, the global blood cancer diagnostics market is anticipated to witness steady growth through 2022. The market will continue to be influenced by regulatory policies and guidelines.

Table of Contents Covered in the report are:

Chapter 1. Global Blood Cancer Diagnostics Market - Executive Summary. 12

Chapter 2. Global Blood Cancer Diagnostics Market Overview. 14
2.1. Introduction. 14
2.1.1. Global Blood Cancer Diagnostics Market Taxonomy. 14
2.1.2. Global Blood Cancer Diagnostics Market Definition. 14
2.2. Global Blood Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 15
2.2.1. Global Blood Cancer Diagnostics Market Y-o-Y Growth. 15
2.3. Global Blood Cancer Diagnostics Market Dynamics. 15
2.3.1. Drivers. 15
2.3.2. Restraints. 16
2.3.3. Trends. 16
2.4. Supply Chain. 16
2.5. Epidemiology. 16
2.6. List of Distributors. 16
2.7. Average Pricing Analysis. 17
2.8. Regulations. 17
2.9. Key Participants Market Presence (Intensity Map) By Region. 17

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=47

Chapter 3. Global Blood Cancer Diagnostics Market Analysis and Forecast By Test Type. 18
3.1. Global Blood Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022. 18
3.1.1. CBC Tests Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 18
3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 18
3.1.1.2. Market Share Comparison, By Region. 20
3.1.1.3. Y-o-Y growth Comparison, By Region. 20
3.1.2. CTC Tests Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 21
3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 21
3.1.2.2. Market Share Comparison, By Region. 23
3.1.2.3. Y-o-Y growth Comparison, By Region. 23
3.1.3. Blood Protein Testing Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 24
3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 24
3.1.3.2. Market Share Comparison, By Region. 26
3.1.3.3. Y-o-Y growth Comparison, By Region. 26
3.1.4. Liquid Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 27
3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 27
3.1.4.2. Market Share Comparison, By Region. 29
3.1.4.3. Y-o-Y growth Comparison, By Region. 29
3.1.5. Bone Marrow Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 30
3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 30
3.1.5.2. Market Share Comparison, By Region. 32
3.1.5.3. Y-o-Y growth Comparison, By Region. 32
3.1.6. Others Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 33
3.1.6.1. Revenue (US$ Mn) Comparison, By Region. 33
3.1.6.2. Market Share Comparison, By Region. 35
3.1.6.3. Y-o-Y growth Comparison, By Region. 35

Access This Report @ https://www.factmr.com/checkout/47/S

Chapter 4. Global Blood Cancer Diagnostics Market Analysis and Forecast By End User. 37
4.1. Global Blood Cancer Diagnostics Market Size and Forecast By End User, 2012-2022. 37
4.1.1. Hospital Associated Labs Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 37
4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 37
4.1.1.2. Market Share Comparison, By Region. 39
4.1.1.3. Y-o-Y growth Comparison, By Region. 39
4.1.2. Independent Diagnostic Laboratories Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 40
4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 40
4.1.2.2. Market Share Comparison, By Region. 42
4.1.2.3. Y-o-Y growth Comparison, By Region. 42
4.1.3. Cancer Research Institutes Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 43
4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 43
4.1.3.2. Market Share Comparison, By Region. 45
4.1.3.3. Y-o-Y growth Comparison, By Region. 45
4.1.4. Others Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 46
4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 46
4.1.4.2. Market Share Comparison, By Region. 48
4.1.4.3. Y-o-Y growth Comparison, By Region. 48

Chapter 5. Global Blood Cancer Diagnostics Market Analysis and Forecast By Region. 50
5.1. Global Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 50
5.1.1. North America Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 50
5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 50
5.1.1.2. Revenue (US$ Mn) Comparison, By End User. 52
5.1.2. Latin America Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 54
5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 54
5.1.2.2. Revenue (US$ Mn) Comparison, By End User. 55
5.1.3. Europe Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 57
5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 57
5.1.3.2. Revenue (US$ Mn) Comparison, By End User. 59
5.1.4. Japan Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 61
5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 61
5.1.4.2. Revenue (US$ Mn) Comparison, By End User. 62
5.1.5. APEJ Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 64
5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 64
5.1.5.2. Revenue (US$ Mn) Comparison, By End User. 66
5.1.6. MEA Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 67
5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 67
5.1.6.2. Revenue (US$ Mn) Comparison, By End User. 69

Chapter 6. North America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 71
6.1. US Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 71
6.1.1. Revenue (US$ Mn) Comparison, By Test Type. 71
6.1.2. Revenue (US$ Mn) Comparison, By End User. 72
6.2. Canada Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 73
6.2.1. Revenue (US$ Mn) Comparison, By Test Type. 73
6.2.2. Revenue (US$ Mn) Comparison, By End User. 74

Chapter 7. Latin America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 75
7.1. Brazil Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 75
7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 75
7.1.2. Revenue (US$ Mn) Comparison, By End User. 76
7.2. Mexico Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 77
7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 77
7.2.2. Revenue (US$ Mn) Comparison, By End User. 78
7.3. Argentina Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 79
7.3.1. Revenue (US$ Mn) Comparison, By Test Type. 79
7.3.2. Revenue (US$ Mn) Comparison, By End User. 80

And Continue...

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trends in the Ready To Use Blood Cancer Diagnostics Market 2018-2020 here

News-ID: 1583926 • Views:

More Releases from Fact.MR

Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033. The surge in luxury eyewear sales
Camping Equipment sales are expected to reach US$ 33.17 billion By 2032
04-24-2024 | Sports
Fact.MR
Camping Equipment sales are expected to reach US$ 33.17 billion By 2032
The global camping equipment market is projected to achieve a substantial value of US$ 33.17 billion by the year 2032, exhibiting a commendable Compound Annual Growth Rate (CAGR) of 7.3% from 2022 to 2032. A surge in expenditure on outdoor recreational activities is poised to ignite significant growth within the camping equipment market. According to insights from Fact.MR, the global camping equipment market is forecasted to reach a valuation of US$
Microbial Algae Products is forecasted to expand at a CAGR of 6.1% from 2024 to 2034
04-24-2024 | Food & Beverage
Fact.MR
Microbial Algae Products is forecasted to expand at a CAGR of 6.1% from 2024 to …
The global microbial algae product market is set to expand at a compound annual growth rate (CAGR) of 6.1%, as outlined in the latest industry research report by Fact.MR. By the end of 2034, the market is anticipated to surge from US$ 3.43 billion in 2024 to US$ 6.2 billion. Recent years have witnessed a notable surge in demand for microbial algae products due to their rich nutritional profile, comprising minerals,
Life Insurance Policy Administration System market is projected to rise at a CAGR of 12.2% through 2034
Life Insurance Policy Administration System market is projected to rise at a CAG …
As per a recent study conducted by Fact.MR, a reputable market research and competitive intelligence firm, the global Life Insurance Policy Administration System Market is poised to grow at a robust Compound Annual Growth Rate (CAGR) of 12.2% until the year 2034. The market is forecasted to achieve a valuation of US$ 6,689.2 million by the end of 2024, with further projections indicating a potential surge to US$ 21,115.2 million

All 5 Releases


More Releases for Comparison

FX-Toprebates.com - Trusted Broker Cashback Comparison
Altenglan - Forex trading is considered one of the best ways for average investors to make a decent and substantial profit even from small investments and a short period of time. Expansion of Forex trading in the market through new investors has significantly driven numerous established brokers to introduce certain programs that will encourage investors to make use of their services. Some of the common incentives involved are cashback and
Acephate Market - Strategies, Comparison, Shares 2023
Acephate is an organophosphate foliar insecticide sold as a soluble powder, as emulsifiable concentrates, as pressurized aerosol, and in tree injection systems and granular formulations. It is basically an insecticide made of esters of phosphoric acid. It is used primarily for control of aphids, including resistant species, in vegetables such as carrots, potatoes, tomatoes and lettuce. Acephate is an organophosphate insecticide. It is used on food crops, citrus trees, as
Moneybrag.com Offers Reliable Financial Comparison Services
Moneybrag.com is a leading online firm that specializes in online comparison services that enable clients to make comparisons of utility and personal finance products. Their primary goal is to provide information in an understandable format that allows for initial comparisons to be made at a glance. This enables customers to make healthy financial decisions. Moneybrag.com gives customers the ability to compare side by side and select a vendor based on
Comparison of Time recording applications
With hiring remote staff and freelancers halfway around the world turning into further common, it is necessary to look out the only thanks to keep track of the hours they work. Not entirely are you able to would like to know the hours to be able to pay them at the tip of the month but together notice an easy due to manage the invoices of an entire team. If
EInsuranceEz.com Launches Health Insurance Comparison Portal
EInsuranceEz.com, the online insurance price comparison company, launched a brand new customer-focused website this month. The site, einsuranceez.com, is designed to offer customers a wide range of competitively-priced life insurance, health insurance and auto insurance quotes instantly online. Working with some of the US biggest providers, EInsuranceEz.com constantly compares the best deals and insurance rates on the market to ensure that the customer gets the greatest saving for them. The company VP
PriceForSure.com - Benefits of Comparison Shopping
Comparison Shopping websites are beneficial to consumers and merchants because they offer a number of benefits. ( EMAILWIRE.COM, June 20, 2007 ) Rincon, Georgia – PriceForSure.com (www.PriceForSure.com) announces the benefits of comparison shopping. This informative and often entertaining form of shopping makes it easier for consumers to find the best deals on the web. Consumers search for products that they are interested in by comparing product types, product features,